CurrentRheuma
Get Weekly

Topic · page 3 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 81–120 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Rheumatology (Oxford)

    Clinical characteristics and long-term outcomes in SLE–myositis overlap syndrome: a controlled retrospective cohort study

    Cohort study

  2. Lupus Sci Med

    Crotonylome profiling identifies MLKL crotonylation in lupus nephritis associated with RAB1A–mTOR signalling and autophagy changes in tubular epithelial cells

    Mechanistic study

  3. Lupus

    A structured primary care–led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice

    Cohort study

  4. Ann Rheum Dis

    Pharmacodynamic analysis of TYK2 inhibition by deucravacitinib: results from the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus

    Secondary analysis

  5. Lancet Rheumatol

    ERN ReCONNET–SLICC–SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)

    Guideline or statement

  6. Rheumatology (Oxford)

    The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review

    Meta-analysis

  7. Lupus

    Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus

    Cross-sectional study

  8. Arthritis Rheumatol

    Interleukin‐12 Signaling Promotes Podocyte Senescence in Lupus Nephritis

    Mechanistic study

  9. Arthritis Rheumatol

    Age‐Specific Incidence of Systemic Lupus Erythematosus in the United States: A Meta‐Analysis of Data From the Centers for Disease Control and Prevention Lupus Registries

    Meta-analysis

  10. Lupus

    Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months

    Cohort study

  11. Lupus

    Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis

    Meta-analysis

  12. Ann Rheum Dis

    Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial

    Randomized controlled trial

  13. Lupus Sci Med

    DIA proteomics of FFPE renal biopsies reveals two molecular subtypes of lupus nephritis and identifies APOL1 as candidate biomarker for stratification

    Mechanistic study

  14. Lupus Sci Med

    Navigating the gap: the challenge of applying treat-to-target in routine lupus care—a national perspective

    Research article

  15. Lupus

    IFI44L promoter hypomethylation as an epigenetic biomarker of systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysis

  16. Lupus Sci Med

    Prevalence and incidence of interstitial lung diseases in systemic lupus erythematosus: systematic review and meta-analyses

    Meta-analysis

  17. Rheumatology (Oxford)

    Systematic review of fatigue assessment instruments for SLE: psychometric validation with COSMIN 2.0 guidelines

    Meta-analysis

  18. Rheumatology (Oxford)

    Describing flares: a mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases

    Cross-sectional study

  19. Rheumatology (Oxford)

    Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis

    Meta-analysis

  20. Lupus

    Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis

    Cohort study

  21. Lupus Sci Med

    Prevalence of falls in a pooled US cohort of adults with systemic lupus erythematosus: a nested cross-sectional study

    Cross-sectional study

  22. Lupus Sci Med

    Subclinical ocular microvascular involvement in primary antiphospholipid syndrome and antiphospholipid antibody carriers

    Cross-sectional study

  23. Lupus

    Psychometric validation and reliability of the Arabic version of the LupusQoL questionnaire (Ar-LupusQoL) in Egyptian patients with systemic lupus erythematosus

    Cross-sectional study

  24. Lupus

    Gut microbiota dysbiosis and plasma lipidomic signatures in systemic lupus erythematosus

    Mechanistic study

  25. Ann Rheum Dis

    Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis

    Mechanistic study

  26. Lupus Sci Med

    The lupus damage index revision program: Results from the item generation and reduction phases

    Guideline or statement

  27. Rheumatology (Oxford)

    Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve

    Cohort study

  28. Arthritis Care Res (Hoboken)

    The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

    Guideline or statement

  29. Lupus

    Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study

    Cohort study

  30. Rheumatology (Oxford)

    Attainment of early targets does not ensure a complete response at 12 months in lupus nephritis, especially in nephrotic-range proteinuria

    Cohort study

  31. Lupus Sci Med

    Immune thrombocytopenia is rare in patients with antiphospholipid syndrome without systemic lupus erythematosus: insights from a series of 351 patients

    Cohort study

  32. Rheumatology (Oxford)

    Early haematologic response to anifrolumab in SLE: results from the European multicentre EFFORT-SLE study

    Cohort study

  33. Arthritis Rheumatol

    Type I Interferon Drives Dysfunction of a Distinct CD8 + HLA ‐ DRB1 + T Cell Subset in Systemic Lupus Erythematosus

    Mechanistic study

  34. Lupus Sci Med

    CD163: a potential biomarker for lupus nephritis activity

    Cross-sectional study

  35. Lupus

    Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis

    Meta-analysis

  36. Rheumatology (Oxford)

    Antiphospholipid antibody trajectories and clinical correlates in an inception cohort of systemic lupus erythematosus

    Cohort study

  37. Rheumatology (Oxford)

    Higher mortality without increased ESKD risk in late-onset SLE with LN versus early-onset SLE: a Latin American cohort

    Cohort study

  38. Arthritis Care Res (Hoboken)

    Prevalence of Major Pulmonary Complications Among Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta‐Analysis

    Meta-analysis

  39. Arthritis Rheumatol

    Anifrolumab Versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus

    Cohort study

  40. Rheumatology (Oxford)

    Pregnancy complications and birth outcomes in women with antiphospholipid antibodies: a Danish population-based cohort study

    Cohort study

All 1,848 Briefs in ExploreShowing Briefs 81–120 of 1,848, newest first